STOCK TITAN

Schedule 13G/A: Perceptive Discloses 4.7% Stake in Anteris Technologies

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Anteris Technologies Global Corp. received a Schedule 13G/A disclosing that Perceptive Advisors LLC, Perceptive Life Sciences Master Fund, Ltd. and Joseph Edelman collectively beneficially own 1,705,130 shares of the issuer's common stock, representing 4.7% of the outstanding class based on 36,062,370 shares outstanding. The Master Fund directly holds the shares; Perceptive Advisors is the fund's investment manager and Mr. Edelman is the managing member, and each may be deemed to beneficially own the shares. No sole voting or dispositive power is reported; all voting and dispositive power is shared.

Positive

  • Clear disclosure of beneficial ownership totaling 1,705,130 shares
  • Ownership percentage provided (4.7% of 36,062,370 shares outstanding)
  • Signatures and certifications included from the reporting persons

Negative

  • None.

Insights

TL;DR: A 4.7% passive stake disclosed by an investment manager and affiliated fund; below the 5% reportable threshold for control but material for ownership monitoring.

The filing shows the Master Fund directly holds 1,705,130 shares (4.7%) with no sole voting or dispositive power reported and all voting/dispositive power listed as shared. Perceptive Advisors, as manager, and Joseph Edelman, as managing member, are identified as persons who may be deemed to beneficially own these shares. The statement is presented on Schedule 13G/A, indicating a passive investor reporting under the applicable rule set rather than an activist 13D filing. This is a straightforward disclosure of ownership useful for cap table tracking and shareholder concentration analysis.

TL;DR: Disclosure clarifies beneficial ownership and voting arrangements but indicates no controlling stake or sole authority.

The report attributes shared voting and dispositive power to the reporting entities while showing zero sole power, which suggests decisions over these shares are not unilaterally controlled by the filer. The filing includes the issuer address and references the outstanding share count used to calculate the 4.7% figure. It contains standard certifications and signatures from Joseph Edelman for all reporting persons, consistent with regulatory requirements.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Perceptive Advisors LLC
Signature:/s/ Joseph Edelman
Name/Title:Joseph Edelman, Managing Member
Date:08/14/2025
Joseph Edelman
Signature:/s/ Joseph Edelman
Name/Title:Joseph Edelman
Date:08/14/2025
Perceptive Life Sciences Master Fund, Ltd.
Signature:/s/ Joseph Edelman
Name/Title:Joseph Edelman, Managing Member
Date:08/14/2025

FAQ

How many shares of Anteris Technologies (AVR) do Perceptive Advisors and affiliates report owning?

They report beneficial ownership of 1,705,130 shares, representing 4.7% of the class.

Does the filing show sole voting or dispositive power for the reported shares?

No. The filing reports 0 sole voting power and 0 sole dispositive power; voting and dispositive power are listed as shared.

Which entities and individuals are listed as reporting persons on this Schedule 13G/A?

The reporting persons are Perceptive Advisors LLC, Perceptive Life Sciences Master Fund, Ltd., and Joseph Edelman.

What share count was used to calculate the ownership percentage?

The percentage is based on 36,062,370 shares outstanding as reported in the issuer's August 11, 2025 filing.

Where is the issuer's principal executive office listed in the filing?

The issuer address is listed as Toowong Tower, Level 3, Suite 302, 9 Sherwood Road, Toowong, QLD, Australia 4066.
ANTERIS TECHNOLOGIES GLOBAL

NASDAQ:AVR

AVR Rankings

AVR Latest News

AVR Latest SEC Filings

AVR Stock Data

192.39M
39.29M
0.21%
47.59%
2.29%
Medical Instruments & Supplies
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
Australia
EAGAN